Oramed Pharmaceuticals, Inc. Share Price OTC Bulletin Board
Equities
US68403P1049
Biotechnology & Medical Research
End-of-day quote
Other stock markets
|
||
- USD | - |
Sales 2024 * | 750K 62.55M | Sales 2025 * | 2M 167M | Capitalization | 92.63M 7.73B |
---|---|---|---|---|---|
Net income 2024 * | - 0 | Net income 2025 * | -14M -1.17B | EV / Sales 2024 * | 124 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 46.3 x |
P/E ratio 2024 * |
-228
x | P/E ratio 2025 * |
-6.91
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 88.73% |
Managers | Title | Age | Since |
---|---|---|---|
Miriam Kidron
FOU | Founder | 83 | 12/02/12 |
Nadav Kidron
CEO | Chief Executive Officer | 50 | 12/02/12 |
Joshua Hexter
COO | Chief Operating Officer | 53 | 14/13/14 |
Members of the board | Title | Age | Since |
---|---|---|---|
Nadav Kidron
CEO | Chief Executive Officer | 50 | 12/02/12 |
Miriam Kidron
FOU | Founder | 83 | 12/02/12 |
Leonard Sank
BRD | Director/Board Member | 59 | 23/07/23 |
1st Jan change | Capi. | |
---|---|---|
+34.01% | 51.07B | |
+34.32% | 38.86B | |
-8.02% | 38.78B | |
-11.12% | 26.69B | |
+12.56% | 26.35B | |
-19.62% | 19.46B | |
+39.18% | 13.58B | |
+31.47% | 12.46B | |
-3.40% | 11.75B |